Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats

Aclan Dogan, Yoshio Suzuki, Naoki Koketsu, Koji Osuka, Kiyoshi Saito, Masakazu Takayasu, Masato Shibuya, Jun Yoshida

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

The intravenous infusion of rat adrenomedullin, at concentrations ranging from 0.1 to 1.0 μg/kg/min, for 60 min increased the regional cerebral blood flow (rCBF) in a dose dependent manner in rats. rCBF was measured using a laser Doppler flowmetry device placed on the surface of the parietal cortex. The increase in rCBF induced by 1.0 μg/kg/min of adrenomedullin was up to 145 ± 10.8% of controls at 60 min (n = 5, p <0.001). These concentrations of adrenomedullin did not affect systemic blood pressure or other physiologic parameters, including pH, P(a)CO2, P(a)O2, hemoglobin, and blood glucose. Repeated infusion of 1.0 μg/kg/min of adrenomedullin at 2-h intervals caused tachyphylaxis (n = 5, p <0.01). Rat adrenomedullin (1.0 μg/kg/min) demonstrated a more potent effect than the same dose of human adrenomedullin. The C-terminal fragment of human adrenomedullin (0.5 and 5.0 μg/kg/min), adrenomedullin22-52, which did not affect rCBF alone, inhibited the effect of rat adrenomedullin (0.5 μg/kg/min) as a receptor antagonist in a dose-dependent manner. In a model of middle cerebral artery (MCA) occlusion in spontaneously hypertensive rats, pre- and postinfusion of 1.0 μg/kg/min of adrenomedullin suppressed the reduction in rCBF following MCA occlusion (control, 29 ± 15.1%; adrenomedullin group, 45 ± 14.4%; not significant) and decreased the volume of ischemic brain injury (control, 288 ± 35 mm3; adrenomedullin group, 232 ± 35 mm3; p <0.05). These results suggest that adrenomedullin increases rCBF and prevents ischemic brain injury, partly by increasing the collateral circulation.

Original languageEnglish (US)
Pages (from-to)19-25
Number of pages7
JournalJournal of Cerebral Blood Flow and Metabolism
Volume17
Issue number1
StatePublished - Jan 1997
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Adrenomedullin
Middle Cerebral Artery Infarction
Regional Blood Flow
Intravenous Infusions
Brain Injuries
Tachyphylaxis
Collateral Circulation
Parietal Lobe
Laser-Doppler Flowmetry
Inbred SHR Rats
Blood Glucose

Keywords

  • Adrenomedullin
  • Middle cerebral artery occlusion
  • NIH Image
  • Regional cerebral blood flow
  • Spontaneously hypertensive rats

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)
  • Endocrinology, Diabetes and Metabolism

Cite this

Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. / Dogan, Aclan; Suzuki, Yoshio; Koketsu, Naoki; Osuka, Koji; Saito, Kiyoshi; Takayasu, Masakazu; Shibuya, Masato; Yoshida, Jun.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 17, No. 1, 01.1997, p. 19-25.

Research output: Contribution to journalArticle

Dogan, Aclan ; Suzuki, Yoshio ; Koketsu, Naoki ; Osuka, Koji ; Saito, Kiyoshi ; Takayasu, Masakazu ; Shibuya, Masato ; Yoshida, Jun. / Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. In: Journal of Cerebral Blood Flow and Metabolism. 1997 ; Vol. 17, No. 1. pp. 19-25.
@article{99dacfdada454276aff5bff19eb76464,
title = "Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats",
abstract = "The intravenous infusion of rat adrenomedullin, at concentrations ranging from 0.1 to 1.0 μg/kg/min, for 60 min increased the regional cerebral blood flow (rCBF) in a dose dependent manner in rats. rCBF was measured using a laser Doppler flowmetry device placed on the surface of the parietal cortex. The increase in rCBF induced by 1.0 μg/kg/min of adrenomedullin was up to 145 ± 10.8{\%} of controls at 60 min (n = 5, p <0.001). These concentrations of adrenomedullin did not affect systemic blood pressure or other physiologic parameters, including pH, P(a)CO2, P(a)O2, hemoglobin, and blood glucose. Repeated infusion of 1.0 μg/kg/min of adrenomedullin at 2-h intervals caused tachyphylaxis (n = 5, p <0.01). Rat adrenomedullin (1.0 μg/kg/min) demonstrated a more potent effect than the same dose of human adrenomedullin. The C-terminal fragment of human adrenomedullin (0.5 and 5.0 μg/kg/min), adrenomedullin22-52, which did not affect rCBF alone, inhibited the effect of rat adrenomedullin (0.5 μg/kg/min) as a receptor antagonist in a dose-dependent manner. In a model of middle cerebral artery (MCA) occlusion in spontaneously hypertensive rats, pre- and postinfusion of 1.0 μg/kg/min of adrenomedullin suppressed the reduction in rCBF following MCA occlusion (control, 29 ± 15.1{\%}; adrenomedullin group, 45 ± 14.4{\%}; not significant) and decreased the volume of ischemic brain injury (control, 288 ± 35 mm3; adrenomedullin group, 232 ± 35 mm3; p <0.05). These results suggest that adrenomedullin increases rCBF and prevents ischemic brain injury, partly by increasing the collateral circulation.",
keywords = "Adrenomedullin, Middle cerebral artery occlusion, NIH Image, Regional cerebral blood flow, Spontaneously hypertensive rats",
author = "Aclan Dogan and Yoshio Suzuki and Naoki Koketsu and Koji Osuka and Kiyoshi Saito and Masakazu Takayasu and Masato Shibuya and Jun Yoshida",
year = "1997",
month = "1",
language = "English (US)",
volume = "17",
pages = "19--25",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats

AU - Dogan, Aclan

AU - Suzuki, Yoshio

AU - Koketsu, Naoki

AU - Osuka, Koji

AU - Saito, Kiyoshi

AU - Takayasu, Masakazu

AU - Shibuya, Masato

AU - Yoshida, Jun

PY - 1997/1

Y1 - 1997/1

N2 - The intravenous infusion of rat adrenomedullin, at concentrations ranging from 0.1 to 1.0 μg/kg/min, for 60 min increased the regional cerebral blood flow (rCBF) in a dose dependent manner in rats. rCBF was measured using a laser Doppler flowmetry device placed on the surface of the parietal cortex. The increase in rCBF induced by 1.0 μg/kg/min of adrenomedullin was up to 145 ± 10.8% of controls at 60 min (n = 5, p <0.001). These concentrations of adrenomedullin did not affect systemic blood pressure or other physiologic parameters, including pH, P(a)CO2, P(a)O2, hemoglobin, and blood glucose. Repeated infusion of 1.0 μg/kg/min of adrenomedullin at 2-h intervals caused tachyphylaxis (n = 5, p <0.01). Rat adrenomedullin (1.0 μg/kg/min) demonstrated a more potent effect than the same dose of human adrenomedullin. The C-terminal fragment of human adrenomedullin (0.5 and 5.0 μg/kg/min), adrenomedullin22-52, which did not affect rCBF alone, inhibited the effect of rat adrenomedullin (0.5 μg/kg/min) as a receptor antagonist in a dose-dependent manner. In a model of middle cerebral artery (MCA) occlusion in spontaneously hypertensive rats, pre- and postinfusion of 1.0 μg/kg/min of adrenomedullin suppressed the reduction in rCBF following MCA occlusion (control, 29 ± 15.1%; adrenomedullin group, 45 ± 14.4%; not significant) and decreased the volume of ischemic brain injury (control, 288 ± 35 mm3; adrenomedullin group, 232 ± 35 mm3; p <0.05). These results suggest that adrenomedullin increases rCBF and prevents ischemic brain injury, partly by increasing the collateral circulation.

AB - The intravenous infusion of rat adrenomedullin, at concentrations ranging from 0.1 to 1.0 μg/kg/min, for 60 min increased the regional cerebral blood flow (rCBF) in a dose dependent manner in rats. rCBF was measured using a laser Doppler flowmetry device placed on the surface of the parietal cortex. The increase in rCBF induced by 1.0 μg/kg/min of adrenomedullin was up to 145 ± 10.8% of controls at 60 min (n = 5, p <0.001). These concentrations of adrenomedullin did not affect systemic blood pressure or other physiologic parameters, including pH, P(a)CO2, P(a)O2, hemoglobin, and blood glucose. Repeated infusion of 1.0 μg/kg/min of adrenomedullin at 2-h intervals caused tachyphylaxis (n = 5, p <0.01). Rat adrenomedullin (1.0 μg/kg/min) demonstrated a more potent effect than the same dose of human adrenomedullin. The C-terminal fragment of human adrenomedullin (0.5 and 5.0 μg/kg/min), adrenomedullin22-52, which did not affect rCBF alone, inhibited the effect of rat adrenomedullin (0.5 μg/kg/min) as a receptor antagonist in a dose-dependent manner. In a model of middle cerebral artery (MCA) occlusion in spontaneously hypertensive rats, pre- and postinfusion of 1.0 μg/kg/min of adrenomedullin suppressed the reduction in rCBF following MCA occlusion (control, 29 ± 15.1%; adrenomedullin group, 45 ± 14.4%; not significant) and decreased the volume of ischemic brain injury (control, 288 ± 35 mm3; adrenomedullin group, 232 ± 35 mm3; p <0.05). These results suggest that adrenomedullin increases rCBF and prevents ischemic brain injury, partly by increasing the collateral circulation.

KW - Adrenomedullin

KW - Middle cerebral artery occlusion

KW - NIH Image

KW - Regional cerebral blood flow

KW - Spontaneously hypertensive rats

UR - http://www.scopus.com/inward/record.url?scp=0031030007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031030007&partnerID=8YFLogxK

M3 - Article

C2 - 8978383

AN - SCOPUS:0031030007

VL - 17

SP - 19

EP - 25

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 1

ER -